BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2055157)

  • 1. Evaluation of the abuse potential of the novel analgesic flupirtine maleate.
    Preston KL; Funderburk FR; Liebson IA; Bigelow GE
    Drug Alcohol Depend; 1991 Mar; 27(2):101-13. PubMed ID: 2055157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the abuse potential of methocarbamol.
    Preston KL; Guarino JJ; Kirk WT; Griffiths RR
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1146-57. PubMed ID: 2703967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.
    Preston KL; Wolf B; Guarino JJ; Griffiths RR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):707-20. PubMed ID: 1501118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse potential and physical dependence liability studies with flupirtine maleate in laboratory animals.
    Sofia RD; Diamantis W; Gordon R
    Postgrad Med J; 1987; 63 Suppl 3():35-40. PubMed ID: 3447127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential.
    Nickel B; Borbe HO; Szelenyi I
    Arzneimittelforschung; 1990 Aug; 40(8):905-8. PubMed ID: 1978681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.
    Mintzer MZ; Griffiths RR
    Drug Alcohol Depend; 1998 Dec; 53(1):49-66. PubMed ID: 10933340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative drug effects and abuse liability of lorazepam, buspirone, and secobarbital in nondependent subjects.
    Sellers EM; Schneiderman JF; Romach MK; Kaplan HL; Somer GR
    J Clin Psychopharmacol; 1992 Apr; 12(2):79-85. PubMed ID: 1573044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of the analgesic flupirtine on automobile driving].
    Biehl B
    Arzneimittelforschung; 1985; 35(1):77-81. PubMed ID: 4039155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related analgesic effects of flupirtine.
    Hummel T; Friedmann T; Pauli E; Niebch G; Borbe HO; Kobal G
    Br J Clin Pharmacol; 1991 Jul; 32(1):69-76. PubMed ID: 1888644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the behavioral effects and abuse liability of ethanol and pentobarbital in recreational sedative abusers.
    Guarino JJ; Roache JD; Kirk WT; Griffiths RR
    NIDA Res Monogr; 1989; 95():453-4. PubMed ID: 2701315
    [No Abstract]   [Full Text] [Related]  

  • 11. Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):978-88. PubMed ID: 3694540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers.
    Zacny JP
    Psychopharmacology (Berl); 2003 Jan; 165(2):146-56. PubMed ID: 12404072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers.
    Zacny JP; Paice JA; Coalson DW
    Pharmacol Biochem Behav; 2012 Jan; 100(3):560-5. PubMed ID: 22085697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.
    Zacny JP; Lichtor SA
    Psychopharmacology (Berl); 2008 Jan; 196(1):105-16. PubMed ID: 17899018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and subjective effects of buspirone and lorazepam in sedative abusers: supra-therapeutic doses.
    Critchfield TS; Griffiths R
    NIDA Res Monogr; 1990; 105():318. PubMed ID: 1876027
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of a new analgesic, flupirtine, on psychomotor performance in humans].
    Müller-Limmroth W
    Arzneimittelforschung; 1985; 35(7):1089-92. PubMed ID: 4052143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers.
    Mintzer MZ; Guarino J; Kirk T; Roache JD; Griffiths RR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):203-15. PubMed ID: 9260068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users.
    Funderburk FR; Griffiths RR; McLeod DR; Bigelow GE; Mackenzie A; Liebson IA; Nemeth-Coslett R
    Drug Alcohol Depend; 1988 Dec; 22(3):215-22. PubMed ID: 3234245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers.
    Mintzer MZ; Griffiths RR
    Behav Pharmacol; 2005 Nov; 16(7):579-84. PubMed ID: 16170235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.